Skip to content

Sign Up

or

Forgot Password?

Don't have an account?

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account?

Analysts revise Broadcom (AVGO) stock price targets

Analysts revise Broadcom (AVGO) stock price targets

Throughout most of 2024, Broadcom (NASDAQ: AVGO) was on a slow, gradual climb in terms of stock price. 

That state of affairs changed as we drew close to mid-December — a smaller, initial surge on account of a rumored new deal with Apple (NASDAQ: AAPL) occurred on December 11, and was followed up a day later with a more decisive move to the upside following the company’s Q4 and full-year 2024 earnings report.

While earnings per share (EPS) beat analyst estimates, revenues came in slightly short of consensus forecasts. However, the market’s reaction was quite positive — the price of Broadcom stock jumped from $180 to $250 in short order.

That 38.88% rally wasn’t sustainable — since then, the price of an AVGO share has receded to $224.41 at press time. This mark represents a 24.67% increase from the prices seen before the earnings report — and the year-to-date (YTD) return on Broadcom stock sits at 106.75%.

AVGO stock price YTD chart. Source: Finbold
AVGO stock price YTD chart. Source: Finbold

Before the release of the earnings call, the average analyst forecast for AVGO stock price was $200 — soon after the report, major Wall Street firms began setting price targets as high as $230 and $250 — although a fair share of bearish sentiment was also present. Now, two highly-regarded equity researchers have revisited their price targets — and they seem quite bullish.

UBS and Morgan Stanley increase AVGO stock price targets

On December 23, Timothy Arcuri, the leader of semiconductor research at UBS, reissued a prior ‘Buy’ rating while raising his price target on Broadcom stock to $270 from $220. This new price target represents a 20.31% upside from the current AVGO stock price.

After a review of Broadcom’s serviceable adressamble market (SAM) disclosures, UBS assessed its view of the company’s custom compute and AI networking segments. As a result, the firm’s revenue estimates for UBS in FY26 and FY27 were raised by roughly 20% and 40%, respectively. 

Arcuri added that: ‘Even with these higher estimates, we still see room for upside given our middle-of-the-road market share assumptions and the strong likelihood of significant SAM expansion if/when Broadcom adds two additional hyperscalers to its AI customer base.’

An ever-so-slightly less bullish outlook was also shared by Morgan Stanley (NYSE: MS) semiconductor researcher Joseph Moore, who reiterated a previous ‘Overweight’ rating on December 20. 

The analyst increased his price target to $265 from $233 — a mark that represents an 18.08% upside from the current AVGO stock price. In a note shared with investors, Moore noted that: ‘Although the AI industry is showing signs of a U-shaped bottom continuing to play out elsewhere, the attractive assessment of the group remained unchanged.’ 

The revised price target came as a result of Morgan Stanley’s deep dive into its semiconductor sector coverage area — readers should note that the firm singled out Nvidia (NASDAQ: NVDA) as the most attractive stock in the entire semiconductor industry.

Featured image via Shutterstock

Latest posts

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Stocks
Services

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.